Somnee is a neurotechnology company developing a non-invasive neuromodulation platform designed to improve sleep quality by optimizing brain activity. The company focuses on addressing sleep disturbances by modulating neural circuits involved in sleep initiation and maintenance rather than relying on pharmacological interventions.

Its system uses personalized brain stimulation protocols delivered through a wearable headband, informed by individual neural patterns. The approach is designed to guide the brain toward sleep-supportive states using adaptive stimulation while remaining easy to use in home environments.

Somnee’s technology is positioned for consumer and applied sleep health use cases, targeting individuals seeking improved sleep performance and recovery. The company frames its platform as a personalized sleep neuromodulation solution rather than a clinical diagnostic or invasive neurotechnology system.